Literature DB >> 22209498

Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging.

Ingrid E C Verhaart1, Rianne J M van Duijn, Brigit den Adel, Arno A W Roest, Jan J G M Verschuuren, Annemieke Aartsma-Rus, Louise van der Weerd.   

Abstract

Lack of dystrophin results in skeletal muscle dystrophy and dilated cardiomyopathy in humans and animal models. To achieve a basic understanding of the natural development of cardiomyopathy in different dystrophinopathy mouse models, left and right ventricular heart function was assessed at different ages in three dystrophinopathy mouse models (mdx, mdx/utrn(+/-) model and mdx/utrn(-/-)) using magnetic resonance imaging. Left ventricular function was significantly decreased, already at 2months in the most severely affected mdx/utrn(-/-) mice. Furthermore, whereas heart function was stable in wild-type mice over time, both mdx and mdx/utrn(+/-) showed a clear decrease at 10months of age, most prominently in the right ventricle. Therefore magnetic resonance imaging is an adequate technique to determine heart function in dystrophinopathy mouse models and can be used to assess the effect of potential therapies.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209498     DOI: 10.1016/j.nmd.2011.10.025

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

1.  Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.

Authors:  Maria Siemionow; Paulina Langa; Sonia Brodowska; Katarzyna Kozlowska; Kristina Zalants; Katarzyna Budzynska; Ahlke Heydemann
Journal:  Stem Cell Rev Rep       Date:  2022-05-19       Impact factor: 6.692

2.  Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells.

Authors:  Suzanne E Berry; Peter Andruszkiewicz; Ju Lan Chun; Jun Hong
Journal:  Stem Cells Transl Med       Date:  2013-09-25       Impact factor: 6.940

3.  Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.

Authors:  Maaike van Putten; Margriet Hulsker; Courtney Young; Vishna D Nadarajah; Hans Heemskerk; Louise van der Weerd; Peter A C 't Hoen; Gert-Jan B van Ommen; Annemieke M Aartsma-Rus
Journal:  FASEB J       Date:  2013-03-04       Impact factor: 5.191

4.  Stachydrine ameliorates pressure overload-induced diastolic heart failure by suppressing myocardial fibrosis.

Authors:  Hui-Hua Chen; Pei Zhao; Wen-Xia Zhao; Jing Tian; Wei Guo; Ming Xu; Chen Zhang; Rong Lu
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

5.  Longitudinal observations of progressive cardiac dysfunction in a cardiomyopathic animal model by self-gated cine imaging based on 11.7-T magnetic resonance imaging.

Authors:  Shigeyoshi Saito; Minori Tanoue; Kasumi Masuda; Yuki Mori; Satoshi Nakatani; Yoshichika Yoshioka; Kenya Murase
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

6.  Mimicking Cardiac Fibrosis in a Dish: Fibroblast Density Rather than Collagen Density Weakens Cardiomyocyte Function.

Authors:  Ariane C C van Spreeuwel; Noortje A M Bax; Bastiaan J van Nierop; Annemieke Aartsma-Rus; Marie-José T H Goumans; Carlijn V C Bouten
Journal:  J Cardiovasc Transl Res       Date:  2017-03-09       Impact factor: 4.132

Review 7.  Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophy.

Authors:  Tirsa L E van Westering; Corinne A Betts; Matthew J A Wood
Journal:  Molecules       Date:  2015-05-15       Impact factor: 4.411

8.  Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Maria Siemionow; M Malik; P Langa; J Cwykiel; S Brodowska; A Heydemann
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

Review 9.  Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy.

Authors:  Ashling Holland; Kay Ohlendieck
Journal:  Biomed Res Int       Date:  2014-03-20       Impact factor: 3.411

Review 10.  The multifaceted view of heart problem in Duchenne muscular dystrophy.

Authors:  Urszula Florczyk-Soluch; Katarzyna Polak; Józef Dulak
Journal:  Cell Mol Life Sci       Date:  2021-06-06       Impact factor: 9.261

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.